Pediarix patient information sheet
WebSAFETY DATA SHEET 1. Identification Product identifier PEDIARIX ... In this instance patients should consult prescribing ... Material name: PEDIARIX 54257 Version #: 20 Revision date: 05-03-2024 Issue date: 06-23-2014 SDS US. Chemical name Common name and synonyms CAS number % WebYou Call the Shots fact sheet about Vaxelis \(DTaP-IPV-Hib-HepB\). This fact sheet has storage, preparation, administration, contraindications, precautions information, and …
Pediarix patient information sheet
Did you know?
WebPEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. … WebOct 29, 2024 · Manufacturer: MSP Vaccine Company Indication: Active immunization against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to Haemophilus influenzae type b (Hib)...
WebJul 13, 2024 · PATIENT INFORMATION. Provide the following information to the parent or guardian: Inform of the potential benefits and risks of immunization with KINRIX. ... INFANRIX, KINRIX, PEDIARIX, and TIP–LOK are trademarks owned by or licensed to the GSK group of companies. The other brand listed is a trademark owned by or licensed to its … WebNov 1, 2024 · Patient Counseling Information Indications and Usage for Infanrix Infanrix is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday). Related/similar drugs
Web17 PATIENT COUNSELING INFORMATION ... concomitantly with PEDIARIX (DTaP-HBV-IPV) [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated ... WebFact Sheet for Patients : EUA Full Prescribing Information: Novavax, Inc: Letter of Authorization Fact Sheet for Healthcare Providers Fact Sheets for Patients ... Pediarix Package Insert: GSK: Pediarix Product Approval Product Approval - Ebola virus disease (EVD) Ervebo Package Insert: Merck & Co, Inc. ...
WebJul 1, 2024 · Quadracel Prescribing Information Package insert / product label Generic name: diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine Dosage form: suspension for intramuscular injection Drug class: Vaccine combinations Medically reviewed by Drugs.com. Last updated on Jul 1, 2024. On This Page
WebBelow you can find the full A-Z list of our products available worldwide. If you are a healthcare professional you can access product information on your local GSKPro website. Or view our worldwide directory to see other markets where we operate. Filter by product area All product areas Vaccines Specialty medicines General medicines A - D E - H matrix blackWebDec 9, 2024 · What is Pediarix Vaccine? Pediarix vaccine is used to help prevent diphtheria, hepatitis B, pertussis, polio and tetanus in children who are ages 6 weeks to 6 years old, … matrix black hair dyeWebINCRUSE ELLIPTA. (umeclidinium 62.5 mcg inhalation powder) Prescribing Information. INFANRIX. (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Suspension for Intramuscular Injection. Prescribing Information. JEMPERLI. (dostarlimab-gxly) Injection. Prescribing Information. matrix bleach time master lightWebControl and Prevention’s (CDC) Vaccine Information Sheets prior to immunization. What is PEDIARIX and what is it used for? PEDIARIX is a vaccine given to children to prevent five … matrix bms 900-3Web17 PATIENT COUNSELING INFORMATION * ... Vaccine Adsorbed) and/or PEDIARIX [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B … matrix blancheWebPATIENT MEDICATION INFORMATION ..... 31. September 06, 2024 Product Monograph Master Template Template Date: September 2024 INFANRIX hexa, Combined diphtheria … matrix blonde tonerWebNov 1, 2024 · Pediarix is indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. Pediarix is approved for use as a 3-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative mothers. matrix block multiplication